AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 21086242 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise
Number of subjects: 21
Study 21086242 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 21
Study 19050389 — intervention group
Group type: EXPERIMENTAL
Intervention: Atazanavir with ritonavir
Number of subjects: 117
Study 19050389 — intervention group
Group type: EXPERIMENTAL
Intervention: Atazanavir without ritonavir
Number of subjects: 117
Study 19050389 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 117
Study 16965776 — intervention group
Group type: COMPARATOR
Intervention: Simvastatin 20 mg and placebo
Number of subjects: 50
Study 16965776 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 20 mg and ramipril 10 mg
Number of subjects: 50
Study 16965776 — intervention group
Group type: COMPARATOR
Intervention: Ramipril 10 mg and placebo
Number of subjects: 50
Study 16965776 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy (simvastatin 20 mg and ramipril 10 mg)
Number of subjects: 50
Study 15717477 — intervention group
Group type: EXPERIMENTAL
Intervention: Measles vaccination
Number of subjects: 5000
Study 15717477 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral polio vaccine (OPV) first dose
Number of subjects: 5000
Study 15717477 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral polio vaccine (OPV) second dose
Number of subjects: 5000
Study 11911558 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol/acetaminophen (37.5 mg/325 mg) tablets QID for 10 days
Number of subjects: 308
Study 11911558 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 308
Study 11911558 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol/acetaminophen
Number of subjects: 308
Study 10414461 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuronal autoantibodies in patients with limited SCLC (12/29 or 41% positive)
Number of subjects: 58
Study 10414461 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuronal autoantibodies of nuclear or cytoplasmic specificity in limited SCLC
Number of subjects: 58
Study 10414461 — intervention group
Group type: COMPARATOR
Intervention: Neuronal autoantibodies and peripheral neuropathy
Number of subjects: 58
Study 10414461 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuronal autoantibody titers during chemotherapy
Number of subjects: 58
Study 10414461 — intervention group
Group type: COMPARATOR
Intervention: Seropositivity for neuronal autoantibodies and survival
Number of subjects: 58
Study 7672496 — intervention group
Group type: EXPERIMENTAL
Intervention: GLP-1 [7-36 amide] 0.15 nmol/kg
Number of subjects: 8
Study 7672496 — intervention group
Group type: EXPERIMENTAL
Intervention: GLP-1 [7-36 amide] 0.5 nmol/kg
Number of subjects: 8
Study 7672496 — intervention group
Group type: EXPERIMENTAL
Intervention: GLP-1 [7-36 amide] 1.5 nmol/kg
Number of subjects: 8
Study 7672496 — intervention group
Group type: EXPERIMENTAL
Intervention: GLP-1 [7-36 amide] 4.5 nmol/kg
Number of subjects: 8
Study 7672496 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.9% NaCl with 1% human serum albumin)
Number of subjects: 8
Study 7672496 — intervention group
Group type: EXPERIMENTAL
Intervention: GLP-1 [7-36 amide] (all doses) after glucose stimulation
Number of subjects: 8
Study 7672496 — intervention group
Group type: EXPERIMENTAL
Intervention: GLP-1 [7-36 amide] (all doses)
Number of subjects: 8
Study 1983712 — intervention group
Group type: EXPERIMENTAL
Intervention: Niperotidine (460 mg administered at 22.00)
Number of subjects: 20
Study 1983712 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 379689 — intervention group
Group type: EXPERIMENTAL
Intervention: Apomorphine
Number of subjects: 5
Study 379689 — intervention group
Group type: EXPERIMENTAL
Intervention: Physostigmine
Number of subjects: 5
Study 379689 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study 379689 — intervention group
Group type: EXPERIMENTAL
Intervention: Levodopa
Number of subjects: 5
Study 379689 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol
Number of subjects: 5
Study 30287050 — intervention group
Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass
Number of subjects: 63
Study 30287050 — intervention group
Group type: COMPARATOR
Intervention: Intensive lifestyle modification and medical management protocol
Number of subjects: 63
Study 28222101 — intervention group
Group type: EXPERIMENTAL
Intervention: Join the Healthy Boat health promotion program
Number of subjects: 1733
Study 28222101 — intervention group
Group type: COMPARATOR
Intervention: Control group (wait-list)
Number of subjects: 1733
Study 25833816 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure Pain Sensitivity (PPS) during Tilt Table Test (TTT)
Number of subjects: 361
Study 25833816 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduction in resting PPS after stress intervention
Number of subjects: 361
Study 23924233 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone Furoate (FF) 100 μg
Number of subjects: 27
Study 23924233 — intervention group
Group type: EXPERIMENTAL
Intervention: Vilanterol (VI) 25 μg
Number of subjects: 27
Study 23924233 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone Furoate and Vilanterol (FF/VI) 100/25 μg
Number of subjects: 27
Study 23924233 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 21350242 — intervention group
Group type: EXPERIMENTAL
Intervention: HRA-O program with personal reinforcement (group sessions or home visits)
Number of subjects: 878
Study 21350242 — intervention group
Group type: COMPARATOR
Intervention: Control group (no personal reinforcement)
Number of subjects: 878
Study 21350242 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (physician training alone)
Number of subjects: 878
Study 19493864 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac Resynchronization Therapy (CRT)
Number of subjects: 813
Study 19493864 — intervention group
Group type: COMPARATOR
Intervention: Control group (no CRT)
Number of subjects: 813
Study 18257343 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginger-partitioned moxibustion
Number of subjects: 221
Study 18257343 — intervention group
Group type: COMPARATOR
Intervention: Oral administration of Chinese patent medicine
Number of subjects: 221
Study 15312215 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetyl-L-cystein (NAC) infusion (150 mg/kg bolus followed by 12.5 mg/kg/hour for 6 hours)
Number of subjects: 53
Study 15312215 — intervention group
Group type: COMPARATOR
Intervention: Dextrose (5% solution) administered at the same dosage as NAC
Number of subjects: 53
Study 11468553 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus and prednisone (with or without cyclosporine)
Number of subjects: 22
Study 11468553 — intervention group
Group type: COMPARATOR
Intervention: Azathioprine/mycophenolate and prednisone with cyclosporine
Number of subjects: 22
Study 9542480 — intervention group
Group type: EXPERIMENTAL
Intervention: Avitriptan (150 mg doses, 2 hours apart)
Number of subjects: 0
Study 9542480 — intervention group
Group type: COMPARATOR
Intervention: Propranolol (80 mg twice a day)
Number of subjects: 0
Study 9542480 — intervention group
Group type: COMPARATOR
Intervention: Avitriptan alone
Number of subjects: 0
Study 7992348 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg mebendazole
Number of subjects: 2294
Study 7992348 — intervention group
Group type: COMPARATOR
Intervention: 400 mg albendazole
Number of subjects: 2294
Study 7992348 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg mebendazole (Janssen)
Number of subjects: 2294
Study 7992348 — intervention group
Group type: COMPARATOR
Intervention: 500 mg mebendazole (Pharmamed)
Number of subjects: 2294
Study 2730505 — intervention group
Group type: EXPERIMENTAL
Intervention: guided mastery treatment based on self‐efficacy theory
Number of subjects: 26
Study 2730505 — intervention group
Group type: EXPERIMENTAL
Intervention: stimulus exposure treatment
Number of subjects: 26
Study 2730505 — intervention group
Group type: COMPARATOR
Intervention: delayed treatment
Number of subjects: 26
Study 805675 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol 160 mg
Number of subjects: 17
Study 805675 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol 320 mg
Number of subjects: 17
Study 805675 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 31274786 — intervention group
Group type: EXPERIMENTAL
Intervention: Scenario plus video
Number of subjects: 36
Study 31274786 — intervention group
Group type: EXPERIMENTAL
Intervention: Scenario
Number of subjects: 36
Study 28380495 — intervention group
Group type: COMPARATOR
Intervention: Double-blind placebo-controlled food challenge (OFC)
Number of subjects: 393
Study 28380495 — intervention group
Group type: EXPERIMENTAL
Intervention: History of anaphylaxis to the causative food
Number of subjects: 393
Study 28380495 — intervention group
Group type: EXPERIMENTAL
Intervention: Older age (per 1 year increase)
Number of subjects: 393
Study 28380495 — intervention group
Group type: EXPERIMENTAL
Intervention: Egg OFC
Number of subjects: 393
Study 26246322 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Protein Intake (TPro) ≥1.0 to <1.2 g · kg(‐1) · d(‐1)
Number of subjects: 117
Study 26246322 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Protein Intake (TPro) ≥1.2 g · kg(‐1) · d(‐1)
Number of subjects: 117
Study 26246322 — intervention group
Group type: COMPARATOR
Intervention: Total Protein Intake (TPro) <1.0 g · kg(‐1) · d(‐1)
Number of subjects: 117
Study 26246322 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in Total Protein Intake (CTPro)
Number of subjects: 117
Study 26246322 — intervention group
Group type: EXPERIMENTAL
Intervention: Metabolic Syndrome Indexes
Number of subjects: 117
Study 23849104 — intervention group
Group type: EXPERIMENTAL
Intervention: Uninterrupted OAC (N=106)
Number of subjects: 213
Study 23849104 — intervention group
Group type: COMPARATOR
Intervention: Interrupted OAC (N=107)
Number of subjects: 213
Study 23849104 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 213
Study 20390281 — intervention group
Group type: EXPERIMENTAL
Intervention: Mud‐bath therapy with mineral water from the Sillene Spring at Chianciano Spa
Number of subjects: 61
Study 19901194 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean heart rate <75 bpm
Number of subjects: 1530
Study 19901194 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean heart rate >90 bpm
Number of subjects: 1530
Study 19901194 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean heart rate as a continuous variable
Number of subjects: 1530
Study 16603829 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipid-lowering agents
Number of subjects: 0
Study 14738231 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate polysomnography (group 1)
Number of subjects: 171
Study 14738231 — intervention group
Group type: COMPARATOR
Intervention: Polysomnography within 6 months (group 2)
Number of subjects: 171
Study 11765592 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetirizine hydrochloride 5 mg and pseudoephedrine hydrochloride 120 mg (CTZ/PSE)
Number of subjects: 36
Study 11765592 — intervention group
Group type: COMPARATOR
Intervention: Xylometazoline hydrochloride 0.1% (XMZ)
Number of subjects: 36
Study 9212355 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Molecular Weight Heparin (LMWH)
Number of subjects: 22
Study 9212355 — intervention group
Group type: COMPARATOR
Intervention: Unfractionated Heparin (UFH)
Number of subjects: 22
Study 7870932 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocaine and ethanol administration
Number of subjects: 6
Study 7870932 — intervention group
Group type: COMPARATOR
Intervention: Cocaine administration
Number of subjects: 6
Study 7870932 — intervention group
Group type: COMPARATOR
Intervention: Ethanol administration
Number of subjects: 6
Study 3759500 — intervention group
Group type: EXPERIMENTAL
Intervention: Keeping a diet diary (self‐monitoring)
Number of subjects: 160
Study 3759500 — intervention group
Group type: EXPERIMENTAL
Intervention: Receiving leaflets describing and recommending cue avoidance
Number of subjects: 160
Study 3759500 — intervention group
Group type: EXPERIMENTAL
Intervention: Being seen in a group
Number of subjects: 160
Study 3759500 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 160
Study 30518331 — intervention group
Group type: EXPERIMENTAL
Intervention: Td + PCV13
Number of subjects: 448
Study 30518331 — intervention group
Group type: COMPARATOR
Intervention: Td alone
Number of subjects: 448
Study 30518331 — intervention group
Group type: COMPARATOR
Intervention: PCV13 alone
Number of subjects: 448
Study 27028499 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV positive women who did not disclose their status to their partner
Number of subjects: 1092
Study 27028499 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV positive women who disclosed their status to their partner
Number of subjects: 1092
Study 27028499 — intervention group
Group type: COMPARATOR
Intervention: HIV negative women
Number of subjects: 1092
Study 24927299 — intervention group
Group type: EXPERIMENTAL
Intervention: IT-based intervention (ManUp)
Number of subjects: 301
Study 24927299 — intervention group
Group type: COMPARATOR
Intervention: Print-based intervention
Number of subjects: 301
Study 22401331 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimized data entry method
Number of subjects: 40
Study 22401331 — intervention group
Group type: COMPARATOR
Intervention: Initial data entry methods
Number of subjects: 40
Study 20721962 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection of activated carbon nanoparticles
Number of subjects: 60
Study 20721962 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection of methylene blue
Number of subjects: 60
Study 20721962 — intervention group
Group type: COMPARATOR
Intervention: Control group (no tracer)
Number of subjects: 60
Study 18287790 — intervention group
Group type: EXPERIMENTAL
Intervention: Dentin with 5,000 ppm F, NaF, silica (D)
Number of subjects: 10
Study 18287790 — intervention group
Group type: EXPERIMENTAL
Intervention: Dentin with 1,100 ppm F, NaF, silica (C)
Number of subjects: 10
Study 18287790 — intervention group
Group type: COMPARATOR
Intervention: Placebo dentifrice with 22 ppm F, silica
Number of subjects: 10
Study 15625254 — intervention group
Group type: EXPERIMENTAL
Intervention: Xenon (70%)
Number of subjects: 30
Study 15625254 — intervention group
Group type: COMPARATOR
Intervention: N(2)O (70%) and desflurane (2%)
Number of subjects: 30
Study 12660266 — intervention group
Group type: EXPERIMENTAL
Intervention: 1200 mg testosterone implant plus daily oral placebo
Number of subjects: 46
Study 12660266 — intervention group
Group type: EXPERIMENTAL
Intervention: 1200 mg testosterone plus oral Q 75 microg/day
Number of subjects: 46
Study 12660266 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 mg testosterone plus oral Q 75 microg/day
Number of subjects: 46
Study 11766652 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimal osteosynthesis in elderly patients with dislocated two-part fractures
Number of subjects: 0
Study 11766652 — intervention group
Group type: EXPERIMENTAL
Intervention: T-plate fixation in younger patients with dislocated two-part fractures
Number of subjects: 0
Study 11766652 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive techniques for three- and four-part fractures in elderly patients
Number of subjects: 0
Study 11766652 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternative therapies such as conservative treatment and plating
Number of subjects: 0
Study 11766652 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary implantation of a prosthesis in four-part fractures in the elderly
Number of subjects: 0
Study 9499783 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjective review of corneal topography
Number of subjects: 38
Study 9499783 — intervention group
Group type: EXPERIMENTAL
Intervention: Relative scale
Number of subjects: 38
Study 9499783 — intervention group
Group type: EXPERIMENTAL
Intervention: Absolute scale
Number of subjects: 38
Study 9499783 — intervention group
Group type: EXPERIMENTAL
Intervention: Experienced reviewers
Number of subjects: 38
Study 9499783 — intervention group
Group type: EXPERIMENTAL
Intervention: Inexperienced reviewers
Number of subjects: 38
Study 9499783 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcon device
Number of subjects: 38
Study 9499783 — intervention group
Group type: EXPERIMENTAL
Intervention: Eyesys device
Number of subjects: 38
Study 9499783 — intervention group
Group type: EXPERIMENTAL
Intervention: Tomey device
Number of subjects: 38
Study 9499783 — intervention group
Group type: EXPERIMENTAL
Intervention: Low myopia (−1.50 to −2.99 D)
Number of subjects: 38
Study 9499783 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium myopia (−3.00 to −4.49 D)
Number of subjects: 38
Study 9499783 — intervention group
Group type: EXPERIMENTAL
Intervention: High myopia (−4.50 to −6.00 D)
Number of subjects: 38
Study 9499783 — intervention group
Group type: EXPERIMENTAL
Intervention: Homogeneous topographic pattern
Number of subjects: 38
Study 7877826 — intervention group
Group type: EXPERIMENTAL
Intervention: 131I-HIPDM injection
Number of subjects: 35
Study 3374026 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzbromarone (non-micronised brands)
Number of subjects: 10
Study 31800798 — intervention group
Group type: EXPERIMENTAL
Intervention: Home visits by nurses after hospital discharge (Intervention Group)
Number of subjects: 44
Study 31800798 — intervention group
Group type: COMPARATOR
Intervention: Conventional follow-up in conventional health services (Control Group)
Number of subjects: 44
Study 31132997 — intervention group
Group type: EXPERIMENTAL
Intervention: CHW
Number of subjects: 12
Study 31132997 — intervention group
Group type: EXPERIMENTAL
Intervention: CHW + CCT
Number of subjects: 12
Study 31132997 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 12
Study 28292763 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic plantar flexion exercise at 40% of the maximal work rate (WRmax)
Number of subjects: 24
Study 26335334 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation prestripping
Number of subjects: 121
Study 26335334 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation poststripping
Number of subjects: 121
Study 26335334 — intervention group
Group type: COMPARATOR
Intervention: Control (no relaxation)
Number of subjects: 121
Study 23605600 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure using a wrist elastic band on the Nei‐Guan acupuncture point, applied 30 minutes prior to spinal anesthesia.
Number of subjects: 152
Study 23605600 — intervention group
Group type: COMPARATOR
Intervention: Control group (no acupressure intervention).
Number of subjects: 152
Study 23605600 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure group.
Number of subjects: 152
Study 22026323 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent-delivered Qigong massage program for 4 months
Number of subjects: 47
Study 19113926 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily teriparatide for 15 months
Number of subjects: 32
Study 19113926 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclic teriparatide for 15 months
Number of subjects: 32
Study 19113926 — intervention group
Group type: COMPARATOR
Intervention: Alendronate alone for 15 months (control group)
Number of subjects: 32
Study 17072741 — intervention group
Group type: EXPERIMENTAL
Intervention: Tennis playing (young players)
Number of subjects: 70
Study 17072741 — intervention group
Group type: EXPERIMENTAL
Intervention: Tennis playing (adult players)
Number of subjects: 70
Study 17072741 — intervention group
Group type: EXPERIMENTAL
Intervention: Tennis playing (adults)
Number of subjects: 70
Study 17072741 — intervention group
Group type: EXPERIMENTAL
Intervention: Tennis playing (children)
Number of subjects: 70
Study 17072741 — intervention group
Group type: EXPERIMENTAL
Intervention: Tennis playing (long-term)
Number of subjects: 70
Study 17072741 — intervention group
Group type: EXPERIMENTAL
Intervention: Tennis playing (impact-loading sports)
Number of subjects: 70
Study 15501412 — intervention group
Group type: EXPERIMENTAL
Intervention: HES+albumin
Number of subjects: 42
Study 15501412 — intervention group
Group type: COMPARATOR
Intervention: albumin
Number of subjects: 42
Study 15501412 — intervention group
Group type: EXPERIMENTAL
Intervention: group 2 (not specified in the abstract)
Number of subjects: 42
Study 15501412 — intervention group
Group type: EXPERIMENTAL
Intervention: group 3 (albumin)
Number of subjects: 42
Study 10674563 — intervention group
Group type: EXPERIMENTAL
Intervention: Cord blood IgE
Number of subjects: 64
Study 9279891 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiolabelled pessary formulation
Number of subjects: 6
Study 9279891 — intervention group
Group type: EXPERIMENTAL
Intervention: Replens (polycarbophil) gel
Number of subjects: 6
Study 8352327 — intervention group
Group type: EXPERIMENTAL
Intervention: Young adult women
Number of subjects: 40
Study 8352327 — intervention group
Group type: COMPARATOR
Intervention: Older adult women
Number of subjects: 40
Study 30985171 — intervention group
Group type: EXPERIMENTAL
Intervention: Pleasant olfactory cues
Number of subjects: 232
Study 30985171 — intervention group
Group type: COMPARATOR
Intervention: Odor blank (neutral)
Number of subjects: 232
Study 30985171 — intervention group
Group type: COMPARATOR
Intervention: Tobacco-related olfactory cues
Number of subjects: 232
Study 28528227 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated care condition
Number of subjects: 182
Study 28528227 — intervention group
Group type: COMPARATOR
Intervention: Standard care condition
Number of subjects: 182
Study 26681703 — intervention group
Group type: EXPERIMENTAL
Intervention: Radio campaign focused on child health, broadcast from March 2012 to January 2015.
Number of subjects: 0
Study 26681703 — intervention group
Group type: EXPERIMENTAL
Intervention: Short radio spots as part of the campaign.
Number of subjects: 0
Study 23702236 — intervention group
Group type: EXPERIMENTAL
Intervention: Speech therapy
Number of subjects: 100
Study 23702236 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of CPAP and speech therapy
Number of subjects: 100
Study 23702236 — intervention group
Group type: COMPARATOR
Intervention: CPAP
Number of subjects: 100
Study 23702236 — intervention group
Group type: COMPARATOR
Intervention: Placebo (sham speech therapy)
Number of subjects: 100
Study 20943717 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training (group A)
Number of subjects: 25
Study 18066631 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care plus choice of chiropractic, acupuncture, or massage
Number of subjects: 444